Cellular localization of activated factor X by Xa-specific probes

Area of Science:

• Oncology
• Hematology
• Biochemistry

Background:

• The coagulation pathway, particularly Factor X activation, is implicated in various cancer types.
• Understanding the in situ generation of activated Factor X (FXa) is crucial for cancer research.

Purpose of the Study:

• To utilize a recombinant antistasin probe for detecting cellular FXa generation within intact tissues.
• To investigate the presence and cellular localization of FXa in different human cancers and normal tissues.

Main Methods:

• Immunohistochemical procedures using a recombinant antistasin probe specific for activated FXa.
• Examination of tumor tissues from small cell lung carcinoma, renal cell carcinoma, malignant melanoma, lung adenocarcinomas, squamous cell lung carcinoma, Hodgkin's disease, breast cancer, and colon cancer.
• Analysis of normal liver, lung, breast, kidney, and placental tissues.

Main Results:

• FXa was detected on tumor cells in small cell lung carcinoma, renal cell carcinoma, and malignant melanoma.
• Tumor-associated macrophages expressed FXa in lung adenocarcinomas, squamous cell lung carcinomas, and Hodgkin's disease.
• Minimal FXa staining was observed in breast and colon cancers, and normal tissues, correlating with a lack of intratumoral coagulation.

Conclusions:

• Recombinant antistasin probes can effectively detect in situ FXa generation in various cancer types.
• FXa generation is associated with specific tumor cells and tumor-associated macrophages in certain cancers.
• The findings support the utility of such probes for studying cell-associated Factor X activation in the tumor microenvironment.